TABLE 1.
Clinical data for patients and serotypes and β-lactamase genes of the eight ceftriaxone-resistant Salmonella isolates
| Isolate no. | Sex of patienta | Age of patient | Isolation date (yr/mo/day) | Underlying disease | Cause of hospitalizationb | Previous antibiotic use | S. enterica serotype (serogroup) | pI | Encoded β-lactamase |
|---|---|---|---|---|---|---|---|---|---|
| B11 | M | 1 yr 5 mos | 00/06/08 | None | AGE | Unknown | Wagenia (B) | 9.0, 5.4 | CMY-2, TEM-1 |
| B25 | M | 10 mos | 00/07/19 | None | AGE | None | Typhimurium (B) | 9.0, 7.6 | CMY-2, unidentified |
| L4 | F | 1 yr 1 mo | 00/07/18 | None | AGE | Unknown | Typhimurium (B) | 9.0, 7.6 | CMY-2, unidentified |
| L5 | F | 33 yrs | 01/10/20 | None | AGE, PID, vaginitis | Cephalexin | Senftenberg (E4) | 9.0 | CMY-2 |
| L6 | M | 7 mos | 01/11/16 | Cerebral palsy | AGE, bronchiolitis | None | Derby (B) | 9.0 | CMY-2 |
| L8 | M | 1 yr 4 mos | 02/06/07 | None | Salmonella group C sepsis | Ampicillin, ceftriaxone | Panama (D1) | 8.4 | CTX-M-14 |
| L9 | F | 2 mos | 02/06/08 | None | AGE, UTI (E. coli) | None | Typhimurium (B) | 9.0, 7.6 | CMY-2, unidentified |
| L10 | F | 65 yrs | 00/10/26 | Ovarian cancer | AGE | Ceftazidime, cefazolin, gentamicin | Duesseldorf (C2) | 9.0 | CMY-2 |
a
M, male; F, female.
b
AGE, acute gastroenteritis; PID, pelvic inflammatory disease; UTI, urinary tract infection.